These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16801088)

  • 1. Do determinants of platelet function co-segregate with genetic markers of type 1 diabetes mellitus?
    Witas HW; Rózalski M; Watała C; Młynarski W; Sychowski R; Bodalski J
    Platelets; 1999; 10(2-3):169-77. PubMed ID: 16801088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation in diabetic microangiopathy.
    Rauch U; Schwippert B; Schultheiss HP; Tschoepe D
    Platelets; 1998; 9(3-4):237-40. PubMed ID: 16793709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM.
    Hilberg T; Eichler E; Gläser D; Schmidt V; Gabriel HH
    Platelets; 2004 Mar; 15(2):101-8. PubMed ID: 15154602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight GTP-binding proteins are altered in platelet hyperaggregation in IDDM.
    Bastyr EJ; Lu J; Stowe R; Green A; Vinik AI
    Oncogene; 1993 Feb; 8(2):515-8. PubMed ID: 8426753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?
    Watala C; Boncler M; Pietrucha T; Trojanowski Z
    Platelets; 1999; 10(1):52-60. PubMed ID: 16801071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X.
    Aurigemma C; Scalone G; Fattorossi A; Sestito A; Lanza GA; Crea F
    Thromb Res; 2009 May; 124(1):116-20. PubMed ID: 19185336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
    Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
    J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice.
    Henry M; Davidson L; Cohen Z; McDonagh PF; Nolan PE; Ritter LS
    Diabetes Res Clin Pract; 2009 Apr; 84(1):11-8. PubMed ID: 19233499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood.
    Watala C; Golański J; Boncler MA; Pietrucha T; Gwoździński K
    Platelets; 1998; 9(5):315-27. PubMed ID: 16793756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children.
    Dogan Y; Akarsu S; Ustundag B; Yilmaz E; Gurgoze MK
    Mediators Inflamm; 2006; 2006(1):59206. PubMed ID: 16864906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
    Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
    Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet hyperreactivity and vasculopathy in insulin dependent diabetes mellitus.
    Dinda AK; Kumar R; Saraya AK
    Platelets; 1992; 3(2):83-6. PubMed ID: 21043867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus.
    Signorello MG; Viviani GL; Armani U; Cerone R; Minniti G; Piana A; Leoncini G
    Thromb Res; 2007; 120(4):607-13. PubMed ID: 17188741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.